6-氧黄治疗了斯普拉格-道利大鼠的焦虑和化疗诱导的神经病变
Shehla Akbar1, Fazal Subhan1, Rida Qamar2
1Department of Pharmacy, CECOS University of IT and Emerging Sciences, Peshawar, Pakistan.
Frontiers in pharmacology
|January 2, 2025
概括
这项研究表明,6-基 (6-HF) 可以有效地治疗化疗诱导的神经病变和焦虑. 这种新型的flavanone为管理这些常见的化疗副作用提供了潜在的治疗方法.
科学领域:
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
- 在瘤学瘤学.
背景情况:
- 化疗显著提高了癌症存活率,但会导致神经毒性和焦虑等衰弱的副作用.
- 解决这些不良影响对于提高癌症治疗期间患者的生活质量至关重要.
研究的目的:
- 研究6-基 (6-HF) 在缓解化疗诱导的神经病变和焦虑方面的双重治疗潜力.
- 评估6-HF作为一种用于管理常见化疗相关毒性的新药.
主要方法:
- 在大鼠中使用西斯普拉丁诱导的神经病变 (CIN) 模型来评估抗神经病变效应.
- 行为测试包括升高加迷宫 (EPM),楼梯测试和开放场的范式来评估抗焦虑活性.
- 测量爪退出值 (PWT) 和爪退出延迟 (PWL) 以量化神经病痛.
主要成果:
- 6-基黄 (6-HF) 显著缓解了在接受西斯普拉丁治疗的老鼠中的机械形,由改善的PWT和PWL表明.
- 6-HF在EPM,楼梯和开放场地测试中表现出类似焦虑缓解的效果,由增加的开放臂探索,中央平台时间和头部浸泡证明.
- 养殖行为得到维持,运动不被抑制,进一步支持6-HF的抗焦虑潜力.
结论:
- 6-基黄 (6-HF) 具有显著的抗神经病和抗焦虑的特性.
- 6-HF为治疗与化疗相关的神经毒性和焦虑症提供了一个有前途的治疗候选者.
- 对6-HF的进一步研究可能会改善接受化疗的癌症患者的支持性护理.
相关概念视频
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
131
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
131
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
139
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
139
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
184
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
184